The writers reported the increased sensitivity to pain following morphine is due to the activation of an immune system receptor, TLR4, designed to detect harmful bacteria.
The study also found when morphine is metabolized in a patient’s body, one metabolite, M6G, can enter the nervous system and relieve pain, but another metabolite, M3G, has no pain-relieving role.
One of the findings was if morphine could be administered along with a molecule to inhibit TLR4, then the unwanted pain could be reduced.
More Articles on Anesthesia:
OIG: Anesthesia Arrangements With ASCs Could Lead to Trouble
Colorado Appeals Court Rules CRNAs Can Administer Anesthesia Without Supervision
Anesthesia Medical Group Venture Raises $42M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
